Latest News
Harbour BioMed IND for HBM7004 accepted by China's NMPA
...
Organon secures FDA approval expanding TOFIDENCE indications for CRS and paediatric COVID-19
10 June 2026 - US healthcare company Organon (NYSE:OGN) on Wednesday announced US Food and Drug Administration (FDA) approval of a supplemental Biologics License Application for TOFIDENCE (tocilizumab-bavi), an intravenous biosimilar to ACTEMRA (toci...
Orionis Biosciences and Novartis form collaboration to advance molecular glue drug discovery
10 June 2026 - Orionis Biosciences, a privately held, clinical-stage life sciences company, announced on Wednesday that it has entered into a multi-year strategic collaboration with Swiss pharmaceutical company Novartis AG (SIX:NOVN) (NYSE:NVS) to di...
Sanofi halts phase 3 MOBILIZE study of riliprubart in CIDP
10 June 2026 - French healthcare company Sanofi S.A. (Euronext Paris:SAN) (Nasdaq:SNY) announced on Wednesday that it will stop the phase 3 MOBILIZE study evaluating riliprubart in patients with chronic inflammatory demyelinating polyneuropathy (CIDP...
GMJ Technologies names new CEO
10 June 2026 - Life sciences tools company GMJ Technologies announced on Tuesday the appointment of Carol Berry as its chief executive officer, effective 1 June 2026.Berry succeeds Tosin Dada, PhD, founder of GMJ Technologies, who will remain as pres...